June 14, 2017 / 11:17 AM / a month ago

BRIEF-Summit Therapeutics Plc Q1 loss £4.8 million

1 Min Read

June 14 (Reuters) - Summit Therapeutics Plc

* Summit Therapeutics reports financial results for the first quarter ended 30 april 2017 and operational progress

* Summit Therapeutics Plc - cash and cash equivalents at 30 april 2017 of £19.4 million compared to £28.1 million at 31 january 2017

* Summit Therapeutics Plc- loss for three months ended 30 april 2017 of £4.8 million compared to a loss of £5.4 million for three months ended 30 april 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below